Drugs as Pretreatment before Electrical Cardioversion
Atrial fibrillation (AF) is the most common arrhythmia found in clinical practice  and is associated with a doubling of overall morbidity and mortality from cardiovascular disease compared to healthy population . While electrical cardioversion (CV) is a widely used and potentially definitive treatment for AF, it is not always successful. Even when sinus rhythm (SR) is achieved, the arrhythmia often recurs. Antiarrhythmic drugs may potentially augment electrical CV efficacy, and may facilitate maintenance of SR. However, use of these agents is not without risk.
KeywordsAtrial Fibrillation Antiarrhythmic Drug Early Recurrence Chronic Atrial Fibrillation Electrical Cardioversion
Unable to display preview. Download preview PDF.
- 1.ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. (2001) J Am Coll Cardiol 38:1266i-ixxGoogle Scholar
- 2.Kannel WB, Wolf PA (1992) Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation mechanisms and management. Raven, New York, pp 81–92Google Scholar
- 13.Botto GL, Belotti G, Ciró A et al, on behalf of the VERAF study group (2002) Verapamil in prevention of early recurrence of atrial fibrillation: final results of the VERAF study. Eur Heart J 23:660Google Scholar